Our previous study revealed that treatment with GSK1482160, a CNS-penetrant P2RX7 antagonist, reduces ATP-induced secretion of EVs containing tau from microglia and misfolded tau accumulation, restoring cognitive function in a young PS19 tauopathy mouse model29. This evidence concerns the gene MAPT and tauopathy.